Biodexa Pharmaceuticals promotes Fiona Sharp to CFO, secretary

TipRanks

Tue, January 6, 2026 astatine 7:41 AM CST 1 min read

Biodexa Pharmaceuticals (BDRX) announced the promotion of Fiona Sharp to CFO and Company Secretary on with her predetermination to the Board of Directors of the Company with contiguous effect. Sharp is simply a elder concern nonrecreational having joined the Company arsenic Group Financial Controller successful December 2019. During her tenure, she has consistently broadened her remit to see galore of the responsibilities of a CFO. Stephen Stamp volition relinquish his roles arsenic CFO and Company Secretary but stay arsenic CEO.

Claim 70% Off TipRanks Premium

• Unlock hedge fund-level information and almighty investing tools for smarter, sharper decisions

• Stay up of the marketplace with the latest quality and investigation and maximize your portfolio's potential

Published archetypal connected TheFly – the eventual root for real-time, market-moving breaking fiscal news. Try Now>>

See the apical stocks recommended by analysts >>

Read More connected BDRX:

Disclaimer & DisclosureReport an Issue

• Biodexa Pharmaceuticals Prices $10 Million U.S. Public Offering to Fund Pipeline

• Biodexa Pharmaceuticals prices 157,000 units astatine $3.28 successful nationalist offering

• Biodexa Pharmaceuticals PLC-ADR trading resumes

• Biodexa Pharmaceuticals PLC-ADR trading halted, volatility trading pause

• Biodexa announces enrollment of archetypal European patients successful Phase 3 Serenta trial